Список литературы

Поставить закладку

Davidoff A.M. Wilms’ tumor. Т. 21 / A.M. Davidoff. – Curr Opin Pediatr, 2009.
Agrons G.A. Rhabdoid tumor of the kidney in children: a comparative study of 21 cases / G.A. Agrons, K.D. Kingsman, B.J. Wagner, C. Sotelo-Avila // AJR. American journal of roentgenology. – 1997. – Т. 168. – Rhabdoid tumor of the kidney in children. – № 2. – С. 447-451.
Gooskens S.L.M. Clear cell sarcoma of the kidney: a review / S.L.M. Gooskens, R. Furtwängler, G.M. Vujanic, J.S. Dome, N. Graf, M.M. van den Heuvel-Eibrink // European Journal of Cancer (Oxford, England: 1990). – 2012. – Т. 48. – Clear cell sarcoma of the kidney. – № 14. – С. 2219-2226.
Pettinato G. Classical and cellular (atypical) congenital mesoblastic nephroma: a clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study / G. Pettinato, J.C. Manivel, M.R. Wick, L.P. Dehner // Human Pathology. – 1989. – Т. 20. – Classical and cellular (atypical) congenital mesoblastic nephroma. – № 7. – С. 682-690.
Reinhard H. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor / H. Reinhard, O. Semler, D. Bürger, U. Bode, M. Flentje, U. Göbel, P. Gutjahr, I. Leuschner, E. Maass, F. Niggli, H.G. Scheel-Walter, M. Stöckle, J.W. Thüroff, J. Tröger, A. Weirich, D. von Schweinitz, A. Zoubek, N. Graf // Klinische Padiatrie. – 2004. – Т. 216. – № 3. – С. 132-140.
Buckley K.S. Pediatric genitourinary tumors. / K.S. Buckley // Current opinion in oncology. – 2011. – Т. 23. – № 3. – С. 297-302.
Rivera M.N. Wilms’ tumour: Connecting tumorigenesis and organ development in the kidney. Т. 5 / M.N. Rivera, D.A. Haber. – Nature Publishing Group, 2005.
Beckwith J.B. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of wilms’ tumor / J.B. Beckwith, N.B. Kiviat, J.F. Bonadio // Fetal and Pediatric Pathology. – 1990. – Т. 10. – № 1-2. – С. 1-36.
Breslow N.E. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor / N.E. Breslow, J.B. Beckwith, E.J. Perlman, A.E. Reeve // Pediatric Blood and Cancer. – 2006. – Т. 47. – № 3. – С. 260-267.
Gadd S. A Children’s Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor / S. Gadd, V. Huff, A.L. Walz, A.H.A.G. Ooms, A.E. Armstrong, D.S. Gerhard, M.A. Smith, J.M. Guidry Auvil, D. Meerzaman, Q.R. Chen, C.H. Hsu, C. Yan, C. Nguyen, Y. Hu, L.C. Hermida, T. Davidsen, P. Gesuwan, Y. Ma, Z. Zong, A.J. Mungall, R.A. Moore, M.A. Marra, J.S. Dome, C.G. Mullighan, J. Ma, D.A. Wheeler, O.A. Hampton, N. Ross, J.M. Gastier-Foster, S.T. Arold, E.J. Perlman // Nature Genetics. – 2017. – Т. 49. – № 10. – С. 1487-1494.
Szychot E. Wilms’ tumor: biology, diagnosis and treatment. / E. Szychot, J. Apps, K. Pritchard-Jones // Translational pediatrics. – 2014. – Т. 3. – № 1. – С. 12-24.
Szychot E. Review of Current Approaches to the Management of Wilms’ Tumor / E. Szychot, A. Brodkiewicz, K. Pritchard-Jones // International Journal of Clinical Reviews. – 2012.
Versteege I. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer / I. Versteege, N. Sévenet, J. Lange, M.F. Rousseau-Merck, P. Ambros, R. Handgretinger, A. Aurias, O. Delattre // Nature. – 1998. – Т. 394. – № 6689. – С. 203-206.
Frühwald M.C. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome / M.C. Frühwald, M. Hasselblatt, S. Wirth, G. Köhler, R. Schneppenheim, J.I.M. Subero, R. Siebert, U. Kordes, H. Jürgens, J. Vormoor // Pediatric Blood & Cancer. – 2006. – Т. 47. – № 3. – С. 273-278.
Андреева Н.А. SMARCA4-ассоциированные злокачественные рабдоидные опухоли: описание клинического случая и обзор литературы / Н.А. Андреева, Э.И. Людовских, Д.М. Коновалов, М.В. Телешова, А.М. Митрофанова, М.А. Курникова, Л.А. Ясько, А.Е. Друй, М.Ю. Горошкова // РЖДГиО. – 2022. – Т. 9. – № 2. – С. 75-84.
Lechner I. A multinational registry for rhabdoid tumors of any anatomical site / I. Lechner. – 2021.
Biegel J.A. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors / J.A. Biegel, L. Tan, F. Zhang, L. Wainwright, P. Russo, L.B. Rorke // Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. – 2002. – Т. 8. – № 11. – С. 3461-3467.
Schneppenheim R. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome / R. Schneppenheim, M.C. Frühwald, S. Gesk, M. Hasselblatt, A. Jeibmann, U. Kordes, M. Kreuz, I. Leuschner, J.I. Martin Subero, T. Obser, F. Oyen, I. Vater, R. Siebert // American Journal of Human Genetics. – 2010. – Т. 86. – № 2. – С. 279-284.
Gooskens S.L. Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol / S.L. Gooskens, N. Graf, R. Furtwängler, F. Spreafico, C. Bergeron, G.L. Ramírez-Villar, J. Godzinski, C. Rübe, G.O. Janssens, G.M. Vujanic, I. Leuschner, A. Coulomb-L’Hermine, A.M. Smets, B. de Camargo, S. Stoneham, H. van Tinteren, K. Pritchard-Jones, M.M. van den Heuvel-Eibrink, International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG) // Nature Reviews. Urology. – 2018. – Т. 15. – Position paper. – № 5. – С. 309-319.
Astolfi A. Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney / A. Astolfi, F. Melchionda, D. Perotti, M. Fois, V. Indio, M. Urbini, C.G. Genovese, P. Collini, N. Salfi, M. Nantron, P. D’Angelo, F. Spreafico, A. Pession // Oncotarget. – 2015. – Т. 6. – № 38. – С. 40934-40939.
Roy A. Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney / A. Roy, V. Kumar, B. Zorman, E. Fang, K.M. Haines, H. Doddapaneni, O.A. Hampton, S. White, A.A. Bavle, N.R. Patel, K.W. Eldin, M. John Hicks, D. Rakheja, P.J. Leavey, S.X. Skapek, J.F. Amatruda, J.G. Nuchtern, M.M. Chintagumpala, D.A. Wheeler, S.E. Plon, P. Sumazin, D.W. Parsons // Nature Communications. – 2015. – Т. 6. – С. 8891.
Ueno-Yokohata H. Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney / H. Ueno-Yokohata, H. Okita, K. Nakasato, S. Akimoto, J. Hata, T. Koshinaga, M. Fukuzawa, N. Kiyokawa // Nature Genetics. – 2015. – Т. 47. – № 8. – С. 861-863.
Kenny C. Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story / C. Kenny, S. Bausenwein, A. Lazaro, R. Furtwängler, S.L.M. Gooskens, M. van den Heuvel Eibrink, C. Vokuhl, I. Leuschner, N. Graf, M. Gessler, M.J. O’Sullivan // The Journal of Pathology. – 2016. – Т. 238. – Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney. – № 5. – С. 617-620.
O’Meara E. Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney / E. O’Meara, D. Stack, C.-H. Lee, A.J. Garvin, T. Morris, P. Argani, J.S. Han, J. Karlsson, D. Gisselson, I. Leuschner, M. Gessler, N. Graf, J.A. Fletcher, M.J. O’Sullivan // The Journal of Pathology. – 2012. – Т. 227. – № 1. – С. 72-80.
Han H. BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney / H. Han, K.C. Bertrand, K.R. Patel, K.E. Fisher, A. Roy, J.A. Muscal, R. Venkatramani // Pediatric Blood & Cancer. – 2020. – Т. 67. – № 4. – С. e28151.
Antonescu C.R. Undifferentiated round cell sarcoma with BCOR internal tandem duplications (ITD) or YWHAE fusions: a clinicopathologic and molecular study / C.R. Antonescu, Y.-C. Kao, B. Xu, Y. Fujisawa, C. Chung, C.D.M. Fletcher, N. Graf, A.J. Suurmeijer, A. Zin, L.H. Wexler, A. Ferrari, G. Bisogno, R. Alaggio // Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc. – 2020. – Т. 33. – Undifferentiated round cell sarcoma with BCOR internal tandem duplications (ITD) or YWHAE fusions. – № 9. – С. 1669-1677.
Сагоян Г.Б. Врожденная мезобластная нефрома. Собственный опыт НИИ детской онкологии и гематологии ФГБУ «НМИЦ онкологии им. Н. Н. Блохина» Минздрава России/ Сагоян Г.Б., Рубанская М.В., Шевцов Д.В., Рубанский М.А., Керимов П.А., Сулейманова А.М., Пименов Р.И., Тёмный А.С., Кириллова О.А., Захарова Е.В., Близнюков О.П., Жуманиёзов Х.И., Казанцев А.П., Варфоломеева С.Р Российский журнал детской гематологии и онкологии 2019;6(4):25–32.
ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma - PubMed [Электронный ресурс]. – URL: https://pubmed.ncbi.nlm.nih.gov/9823307/ (дата обращения: 28.05.2024).
Watanabe N. Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type / N. Watanabe, M. Haruta, H. Soejima, D. Fukushi, K. Yokomori, H. Nakadate, H. Okita, J. Hata, M. Fukuzawa, Y. Kaneko // Genes, Chromosomes & Cancer. – 2007. – Т. 46. – № 10. – С. 929-935.
Chu A. Wilms’ tumour: A systematic review of risk factors and meta-analysis. Т. 24 / A. Chu, J.E. Heck, K.B. Ribeiro, P. Brennan, P. Boffetta, P. Buffler, R.J. Hung. – 2010.
Spreafico F. Wilms’ tumor: Past, present and (possibly) future. Т. 6 / F. Spreafico, F.F. Bellani. – Expert Rev Anticancer Ther, 2006.
Sultan I. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors / I. Sultan, I. Qaddoumi, C. Rodríguez-Galindo, A.A. Nassan, K. Ghandour, M. Al-Hussaini // Pediatric Blood & Cancer. – 2010. – Т. 54. – № 1. – С. 35-40.
UMBRELLA Protocol SIOP-RTSG 2016 [Электронный ресурс]. – URL: http://www.fnkc.ru/docs/SIOP-RTSG2016.pdf.
Heck J.E. Epidemiology of Rhabdoid Tumors of Early Childhood / J.E. Heck, C.A. Lombardi, M. Cockburn, T.J. Meyers, M. Wilhelm, B. Ritz // Pediatric blood & cancer. – 2013. – Т. 60. – № 1. – С. 77-81.
Nakata K. Incidence of childhood renal tumours: An international population-based study / K. Nakata, M. Colombet, C.A. Stiller, K. Pritchard-Jones, E. Steliarova-Foucher, IICC-3 Contributors // International Journal of Cancer. – 2020. – Т. 147. – Incidence of childhood renal tumours. – № 12. – С. 3313-3327.
Argani P. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center / P. Argani, E.J. Perlman, N.E. Breslow, N.G. Browning, D.M. Green, G.J. D’Angio, J.B. Beckwith // The American Journal of Surgical Pathology. – 2000. – Т. 24. – Clear cell sarcoma of the kidney. – № 1. – С. 4-18.
Reza Alaghehbandan. What’s new in the WHO 2022 classification of kidney tumours?/ Reza Alaghehbandan, Farshid Siadat, Kiril Trpkov//Pathologica. 2023 Feb; 115(1): 8–22.
Beckwith J.B. National Wilms Tumor Study: An update for pathologists / J.B. Beckwith // Pediatric and Developmental Pathology. – 1998. – Т. 1. – № 1. – С. 79-84.
Green D.M. Wilms’ Tumor / D.M. Green // Diagnosis and Management of Malignant Solid Tumors in Infants and Children. – Springer US, 1985. – С. 129-186.
Israels T. SIOP PODC: Clinical guidelines for the management of children with Wilms tumour in a low income setting / T. Israels, C. Moreira, T. Scanlan, L. Molyneux, S. Kampondeni, P. Hesseling, H. Heij, E. Borgstein, G. Vujanic, K. Pritchard-Jones, L. Hadley // Pediatric Blood and Cancer. – 2013. – Т. 60. – № 1. – С. 5-11.
Scott R.H. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. Т. 43 / R.H. Scott, C.A. Stiller, L. Walker, N. Rahman. – BMJ Publishing Group, 2006.
Magee F. Neural differentiation in Wilms’ tumor. / F. Magee, R.G. Mah, G.P. Taylor, J.E. Dimmick // Human pathology. – 1987. – Т. 18. – № 1. – С. 33-7.
Sandoval J.A. Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors / J.A. Sandoval, L.H. Malkas, R.J. Hickey // International Journal of Molecular Sciences. – 2012. – Т. 13. – № 1. – С. 1126-1153.
Детская онкология. Национальное руководство. Под ред. М.Д. Алиева, В.Г. Полякова, Г.Л. Менткевича, С.А. Маяковой. – М.: Издательская группа РОНЦ. Практическая медицина, 2012. – 684 с.
Zamperlini-Netto G. PO-60 - Renal tumors with extensive vascular disease: management challenges in a pediatric series from the Hospital for Sick Children. / G. Zamperlini-Netto, A. Zanette, E. Wehbi, S. Williams, R.M. Grant, L.R. Brandao // Thrombosis research. – 2016. – Т. 140 Suppl 1. – С. S198-9.
Riccabona M. Imaging of renal tumours in infancy and childhood. Т. 13 / M. Riccabona. – 2003.
Grundy P.E. Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: A report from the Children’s Oncology Group / P.E. Grundy, D.M. Green, A.C. Dirks, A.E. Berendt, N.E. Breslow, J.R. Anderson, J.S. Dome // Pediatric Blood and Cancer. – 2012. – Т. 59. – № 4. – С. 631-635.
Smets A.M.J.B. The contribution of chest CT-scan at diagnosis in children with unilateral Wilms’ tumour. Results of the SIOP 2001 study / A.M.J.B. Smets, H. Van Tinteren, C. Bergeron, B. De Camargo, N. Graf, K. Pritchard-Jones, J. De Kraker // European Journal of Cancer. – 2012. – Т. 48. – № 7. – С. 1060-1065.
Stanescu A.L. Pediatric Renal Neoplasms:: MR Imaging–Based Practical Diagnostic Approach. Т. 27 / A.L. Stanescu, P.T. Acharya, E.Y. Lee, G.S. Phillips. – W.B. Saunders, 2019.
Casanova M. Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol / M. Casanova, A. Ferrari, G. Bisogno, J.H.M. Merks, G.L. De Salvo, C. Meazza, K. Tettoni, M. Provenzi, I. Mazzarino, M. Carli // Cancer. – 2004. – Т. 101. – Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas. – № 7. – С. 1664-1671.
Heuvel-Eibrink M.M. van den. Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol / M.M. van den Heuvel-Eibrink, J.A. Hol, K. Pritchard-Jones, H. van Tinteren, R. Furtwängler, A.C. Verschuur, G.M. Vujanic, I. Leuschner, J. Brok, C. Rübe, A.M. Smets, G.O. Janssens, J. Godzinski, G.L. Ramírez-Villar, B. de Camargo, H. Segers, P. Collini, M. Gessler, C. Bergeron, F. Spreafico, N. Graf, International Society of Paediatric Oncology — Renal Tumour Study Group (SIOP–RTSG) // Nature Reviews. Urology. – 2017. – Т. 14. – Position paper. – № 12. – С. 743-752.
Voss S.D. Staging and following common pediatric malignancies: MRI versus CT versus functional imaging. Т. 48 / S.D. Voss. – Springer Verlag, 2018.
Agarwala S. High incidence of adriamycin cardiotoxicity in children even at low cumulative doses: Role of radionuclide cardiac angiography / S. Agarwala, R. Kumar, V. Bhatnagar, M. Bajpai, D.K. Gupta, D.K. Mitra // Journal of Pediatric Surgery. – 2000. – Т. 35. – № 12. – С. 1786-1789.
Blatt J. Pilot study of cardiac function after treatment of childhood wilms’ tumor with doxorubicin / J. Blatt, C. Delaat, F.J. Fricker, J.E. Janosky // Pediatric Hematology and Oncology. – 1995. – Т. 12. – № 1. – С. 61-66.
Massin M.M. Acute arrhythmogenicity of first-dose chemotherapeutic agents in children / M.M. Massin, M.F. Dresse, V. Schmitz, C. Hoyoux, J.M. Chantraine, P. Lepage // Medical and Pediatric Oncology. – 2002. – Т. 39. – № 2. – С. 93-98.
13. Brooks B. Ototoxicity monitoring in children treated with platinum chemotherapy / B. Brooks, K. Knight // International Journal of Audiology. – 2018. – Т. 57. – № sup4. – С. S34-S40.
Durrant J.D. American Academy of Audiology Position Statement and Clinical Practice Guidelines: Ototoxicity Monitoring Task Force Members / J.D. Durrant, K. Campbell, S. Fausti, G. Jacobson, B.L. Lonsbury-Martin, L. Linda. – 2009.
Ünal E. Twenty children with non-wilms renal tumors from a reference center in central anatolia, Turkey / E. Ünal, E. Yilmaz, A. Özcan, B. Işik, M. Karakükcü, C. Turan, H. Akgün, F. Öztürk, A. Coşkun, M.A. Özdemir, T. Patiroğlu // Turkish Journal of Medical Sciences. – 2020. – Т. 50. – № 1. – С. 18-24.
Vujanić G.M. The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms Tumor Study 3 / G.M. Vujanić, A. Kelsey, C. Mitchell, R.S. Shannon, P. Gornall // Medical and Pediatric Oncology. – 2003. – Т. 40. – № 1. – С. 18-22.
Jackson T.J. How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group / T.J. Jackson, H.J. Brisse, K. Pritchard-Jones, K. Nakata, C. Morosi, T. Oue, S. Irtan, G. Vujanic, M.M. van den Heuvel-Eibrink, N. Graf, T. Chowdhury, SIOP RTSG Biopsy Working Group // Pediatric Blood & Cancer. – 2022. – Т. 69. – How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy. – № 9. – С. e29702.
Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Oldervoll L, Ravasco P, Solheim TS, Strasser F, de van der Schueren M, Preiser JC, Bischoff SC. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021; 40(5):2898-2913. doi: 10.1016/j.clnu.2021.02.005.
Трахтман П.Е., Старостин Н.Н., Новичкова Г.А., Ворожцов И.Н. Трансфузионная терапия в клинической практике: учеб. пособие / Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Д. Рогачева. Москва, 2021. 76 с.
Patel P. Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysis. // Patel P, Robinson PD, Wahib N [et al] // Support Care Cancer. 2022 Nov;30(11):8855-8869. doi: 10.1007/s00520-022-07287-w.
Heuvel-Eibrink M.M. Van Den. Position Paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol / M.M. Van Den Heuvel-Eibrink, J.A. Hol, K. Pritchard-Jones, H. Van Tinteren, R. Furtwängler, A.C. Verschuur, G.M. Vujanic, I. Leuschner, J. Brok, C. Rübe, A.M. Smets, G.O. Janssens, J. Godzinski, G.L. Ramírez-Villar, B. De Camargo, H. Segers, P. Collini, M. Gessler, C. Bergeron, F. Spreafico, N. Graf // Nature Reviews Urology. – 2017. – Т. 14. – № 12. – С. 743-752.
Kieran K. Current surgical standards of care in Wilms tumor. Т. 34 / K. Kieran, P.F. Ehrlich. – Elsevier Inc., 2016.
Israels T. The efficacy and toxicity of SIOP preoperative chemotherapy in Malawian children with a Wilms tumour / T. Israels, G. Chagaluka, D. Pidini, H. Caron, J. de Kraker, S. Kamiza, E. Borgstein, L. Molyneux // Pediatric Blood and Cancer. – 2012. – Т. 59. – № 4. – С. 636-641.
Alkazemi M.H. Partial and radical nephrectomy in children, adolescents, and young adults: Equivalent readmissions and postoperative complications / M.H. Alkazemi, Z.R. Dionise, R. Jiang, S. Wolf, G.M. Pomann, E.T. Tracy, H.E. Rice, J.C. Routh // Journal of Pediatric Surgery. – 2019. – Т. 54. – № 11. – С. 2343-2347.
Cox S. Surgery for the complex Wilms tumour / S. Cox, C. Büyükünal, A.J.W. Millar // Pediatric Surgery International. – 2020. – Т. 36. – № 2. – С. 113-127.
Fuchs J. Surgical aspects in the treatment of patients with unilateral wilms tumor: A report from the SIOP 93-01/German society of pediatric oncology and hematology / J. Fuchs, K. Kienecker, R. Furtwängler, S.W. Warmann, D. Bürger, J.W. Thürhoff, J. Hager, N. Graf // Annals of Surgery. – 2009. – Т. 249. – № 4. – С. 666-671.
Walker J.P. Factors affecting lymph node sampling patterns and the impact on survival of lymph node density in patients with Wilms tumor: a Surveillance, Epidemiology, and End Result (SEER) database review / J.P. Walker, J.S. Johnson, M.M. Eguchi, A.F. Saltzman, M. Cockburn, N.G. Cost // Journal of Pediatric Urology. – 2019.
Godzinski J. Current concepts in surgery for Wilms tumor-the risk and function-adapted strategy. Т. 24 / J. Godzinski, N. Graf, G. Audry. – Georg Thieme Verlag, 2014.
Godzinski J. The current status of treatment of Wilms’ tumor as per the SIOP trials. Т. 20 / J. Godzinski. – Medknow Publications, 2014.
Kieran K. Repeat nephron-sparing surgery for children with bilateral Wilms tumor / K. Kieran, M.A. Williams, L.M. McGregor, J.S. Dome, M.J. Krasin, A.M. Davidoff // Journal of Pediatric Surgery. – 2014. – Т. 49. – № 1. – С. 149-153.
Varlet F. Laparoscopic radical nephrectomy for unilateral renal cancer in children / F. Varlet, J.L. Stephan, E. Guye, R. Allary, C. Berger, M. Lopez // Surgical Laparoscopy, Endoscopy and Percutaneous Techniques. – 2009. – Т. 19. – № 2. – С. 148-152.
Varlet F. Laparoscopic treatment of renal cancer in children: A multicentric study and review of oncologic and surgical complications / F. Varlet, T. Petit, M.D. Leclair, H. Lardy, S. Geiss, F. Becmeur, P. Ravasse, J. Rod, G. De Lambert, K. Braik, F. Lardellier-Reynaud, M. Lopez // Journal of Pediatric Urology. – 2014. – Т. 10. – № 3. – С. 500-505.
Dome J.S. Treatment of anaplastic histology Wilms’ tumor: Results from the fifth National Wilms’ Tumor Study / J.S. Dome, C.A. Cotton, E.J. Perlman, N.E. Breslow, J.A. Kalapurakal, M.L. Ritchey, P.E. Grundy, M. Malogolowkin, J.B. Beckwith, R.C. Shamberger, G.M. Haase, M.J. Coppes, P. Coccia, M. Kletzel, R.M. Weetman, M. Donaldson, R.M. Macklis, D.M. Green // Journal of Clinical Oncology. – 2006. – Т. 24. – № 15. – С. 2352-2358.
Green D.M. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms’ tumor: A report from the National Wilms’ Tumor Study Group / D.M. Green, N.E. Breslow, J.B. Beckwith, J.Z. Finklestein, P. Grundy, P.R. Thomas, T. Kim, S. Shochat, G. Haase, M. Ritchey, P. Kelalis, G.J. D’Angio // Journal of Clinical Oncology. – 1998. – Т. 16. – № 12. – С. 3744-3751.
Malogolowkin M. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the national Wilms tumor study group / M. Malogolowkin, C.A. Cotton, D.M. Green, N.E. Breslow, E. Perlman, J. Miser, M.L. Ritchey, P.R.M. Thomas, P.E. Grundy, G.J. D’Angio, J.B. Beckwith, R.C. Shamberger, G.M. Haase, M. Donaldson, R. Weetman, M.J. Coppes, P. Shearer, P. Coccia, M. Kletzel, R. Macklis, G. Tomlinson, V. Huff, R. Newbury, D. Weeks // Pediatric Blood and Cancer. – 2008. – Т. 50. – № 2. – С. 236-241.
Mitchell C. The treatment of Wilms’ tumour: Results of the United Kingdom Children’s Cancer Study Group (UKCCSG) second Wilms’ tumour study / C. Mitchell, P. Morris Jones, A. Kelsey, G.M. Vujanic, B. Marsden, R. Shannon, P. Gornall, C. Owens, R. Taylor, J. Imeson, H. Middleton, J. Pritchard // British Journal of Cancer. – 2000. – Т. 83. – № 5. – С. 602-608.
Pritchard J. Results of the United Kingdom Children’s Cancer Study Group first Wilms’ tumor study / J. Pritchard, J. Imeson, J. Barnes, S. Cotterlll, D. Gough, H.B. Marsden, P. Morris-Jones, D. Pearson // Journal of Clinical Oncology. – 1995. – Т. 13. – № 1. – С. 124-133.
Arunagiri N. The spleen as an organ at risk in paediatric radiotherapy: A SIOP-Europe Radiation Oncology Working Group report / N. Arunagiri, S.M. Kelly, C. Dunlea, O. Dixon, J. Cantwell, P. Bhudia, T. Boterberg, G.O. Janssens, J.E. Gains, Y.-C. Chang, M.N. Gaze, SIOP-Europe Radiation Oncology Working Group // European Journal of Cancer (Oxford, England: 1990). – 2021. – Т. 143. – The spleen as an organ at risk in paediatric radiotherapy. – С. 1-10.
Hamilton T.E. The management of synchronous bilateral wilms tumor: A report from the National Wilms Tumor Study Group / T.E. Hamilton, M.L. Ritchey, G.M. Haase, P. Argani, S.M. Peterson, J.R. Anderson, D.M. Green, R.C. Shamberger // Annals of Surgery. – 2011. – Т. 253. – № 5. – С. 1004-1010.
Indolfi P. Synchronous bilateral Wilms tumor: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) / P. Indolfi, A. Jenkner, M. Terenziani, A. Crocoli, A. Serra, P. Collini, D. Biasoni, L. Gandola, G. Bisogno, G. Cecchetto, M. Di Martino, P. D’Angelo, M. Bianchi, M. Conte, A. Inserra, A. Pession, F. Spreafico // Cancer. – 2013. – Т. 119. – № 8. – С. 1586-1592.
Owens C.M. Bilateral disease and new trends in Wilms tumour / C.M. Owens, H.J. Brisse, Ø.E. Olsen, J. Begent, A.M. Smets // Pediatric Radiology. – Pediatr Radiol, 2008. – Т. 38. – С. 30-39.
Sudour H. Bilateral Wilms tumors (WT) treated with the SIOP 93 protocol in France: Epidemiological survey and patient outcome / H. Sudour, G. Audry, G. Schleimacher, C. Patte, S. Dussart, C. Bergeron // Pediatric Blood and Cancer. – 2012. – Т. 59. – № 1. – С. 57-61.
Вашура А.Ю. Нутритивная недостаточность, ее причины и пути коррекции у детей с опухолями ЦНС на этапе активной терапии и после ее окончания. Фарматека. 2019; 26 (10): 8–14.
Парентеральное и энтеральное питание: национальное руководство / под ред. М.Ш. Хубутия, Т.С. Поповой, А.И. Салтанова. – М.: ГЭОТАР-Медиа, 2014. – 800с.
Mehta NM, Corkins MR, Lyman B, Malone A, Goday PS, Carney LN, Monczka JL, Plogsted SW, Schwenk WF; American Society for Parenteral and Enteral Nutrition Board of Directors. Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions. JPEN J Parenter Enteral Nutr. 2013;37(4):460-81. doi: 10.1177/0148607113479972.
Алымова Ю.А., Вашура А.Ю. Адекватная оценка нутритивного статуса в детской онкологии и гематологии - первый этап нутритивного сопровождения. Трудный пациент. 2019; Т. 17. № 8 (9). С. 54-59.
Martin L. et al. Diagnostic criteria for the classification of cancer-associated weight loss // J. Clin. Oncol. American Society of Clinical Oncology, 2015. Vol. 33, № 1. P. 90–99.
Kondrup J. et al. ESPEN guidelines for nutrition screening 2002 // Clin. Nutr. Churchill Livingstone, 2003. Vol. 22, № 4. P. 415–421; Arends J. et al. ESPEN guidelines on nutrition in cancer patients // Clin. Nutr. Churchill Livingstone, 2017. Vol. 36, № 1. P. 11–48.
Вашура АЮ, Кучер МА, Ковтун ТА, Алымова ЮA, Литвинов ДВ, Зубаровская ЛС, Кулагин АД. Роль и актуальность нутрициологического диагноза в онкопедиатрии. Медицинский Совет. 2023;(12):99-109.
Yaprak D.S, Yalçın B., Pınar A.A., Büyükpamukçu M. Assessment of nutritional status in children with cancer: Significance of arm anthropometry and serum visceral proteins. Pediatr Blood Cancer. 2021;68(1):28752.
Методические указания. Порядок проведения клинических исследований для оценки эффективности специализированной пищевой продукции диетического лечебного и диетического профилактического питания/ ФГБУН «ФИЦ питания и биотехнологии», Роспотребнадзор, Минздрав России, ФГБУН «ФНЦГ им. Ф.Ф.Эрисмана» Роспотребнадзора. - Москва. – 2023. – 28с.
Методическое руководство. Стандарты лечебного питания/ ФГБУН «ФИЦ питания и биотехнологии». - Москва. – 2017. – 338с.
Вашура А.Ю., Пятаева А.А., Карелин А.Ф. Питание и нутритивная поддержка детей со злокачественными новообразованиями после завершения лечения: основные аспекты. Вопросы детской диетологии. 2022; 20(6): 64–70.
Rayar M., Webber C.E., Nayiager T., Sala A., Barr R.D. Sarcopenia in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2013;35:98-102; Pietila S., Makipernaa A., Sievanen H., Koivisto A.M., Wigren T., Lenko H.L. Obesity and metabolic changes are common in young childhood brain tumor survivors. Pediatr Blood Cancer. 2009;52:853-9.
Joosten K, Embleton N, Yan W, Senterre T; ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy. Clin Nutr. 2018;37(6 Pt B):2309-2314. doi:10.1016/j.clnu.2018.06.944.
Особенности нутриционной поддержки больных в педиатрии. В кн.: Клиническое питание больных в интенсивной медицине: практическое руководство /под ред. Луфта В. М., Багненко С. Ф., издание второе, дополненное. СПб.: Арт-Экспресс, 2013–460.
Парентеральное и энтеральное питание детей. Практические рекомендации. Под ред. Ерпулевой Ю.В., Чубаровой А.И., Чугуновой Ю.Л. ГЭОТАР-Медиа, 2016г. 304с.; Arends J. et al. ESPEN guidelines on nutrition in cancer patients // Clin. Nutr. Churchill Livingstone, 2017. Vol. 36, № 1. P. 11–48.
Современные рекомендации по питанию детей / под ред. Проф. Ю.Г. Мухиной, проф. И.Я. Коня. – М.: ИД «МЕДПРАКТИКА-М», 2010,568с.
Ерпулёва Ю. В. Парентеральное питание у детей Российский вестник детской хирургии, анестезиологии и реаниматологии. 2018; 8(1):49-56
Hesketh, P.J. Antiemetics: ASCO Guideline Update / P.J. Hesketh, M.G. Kris, E. Basch [et al.] // J Clin Oncol. – 2020. – JCO2001296. – doi:10.1200/JCO.20.01296
Жуков, Н.В. Эффективность и безопасность малых доз оланзапина в профилактике тошноты и рвоты у детей и подростков, получающих высокоэметогенную химиотерапию. Промежуточные результаты рандомизированного исследования / Н.В. Жуков, Л.Л. Рабаева, Д.В. Литвинов // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. – 2022. − №4. – С. 70–82. doi: 10.24287/1726-1708-2022-21-4-70-82;
Jain S. A randomized, open-label non-inferiority study to compare palonosetron and ondansetron for prevention of acute chemotherapy-induced vomiting in children with cancer receiving moderate or high emetogenic chemotherapy / Jain S., Kapoor G, Koneru S, Vishwakarma G // Support Care Cancer - 2018 Sep;26(9):3091-3097. doi: 10.1007/s00520-018-4158-5;
Patel P. Dexamethasone dosing for prevention of acute chemotherapy-induced vomiting in pediatric patients: A systematic review / Patel P, Olteanu A, Cabral S, Santesso N, Robinson PD, Dupuis LL. // Pediatr Blood Cancer. 2020 Dec;67(12):e28716. doi: 10.1002/pbc.28716.
Ramavath, D.N. Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator-Initiated, Randomized, Open-Label Trial / D.N. Ramavath, V. Sreenivas, S. Vishwajeet [et al.] // Journal of Clinical Oncology. – 2020. – Vol. 38 (32). – P. 3785-3793. – doi: 10.1200/JCO.20.00871.
Chaudhary, N.K. Palonosetron is a Better Choice Compared with Ondansetron for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in a Resource-limited Pediatric Oncology Center: Results from a Randomized Control Trial / N.K. Chaudhary, R.R. John, D. Boddu [et al.] // J Pediatr Hematol Oncol. – 2019. – Vol. 41 (4). – P. 294-297. – doi: 10.1097/MPH.0000000000001357.
Flank, J. Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children with Cancer / J. Flank, P.D. Robinson, M. Holdsworth [et al.] // Pediatr Blood Cancer. – 2016. – Vol. 63 (7). – P. 1144-1151. – doi:10.1002/pbc.25955.
Paw Cho Sing E, Robinson PD, Flank J, Holdsworth M, Thackray J, Freedman J, Gibson P, Orsey AD, Patel P, Phillips R, Portwine C, Raybin JL, Cabral S, Sung L, Dupuis LL. Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline. Pediatr Blood Cancer. 2019 May;66(5):e27646. doi: 10.1002/pbc.27646. Epub 2019 Feb 7. Erratum in: Pediatr Blood Cancer. 2021 May;68(5):e28990. doi: 10.1002/pbc.28990. PMID: 30729654.
Жуков, Н.В. Профилактика и лечение тошноты и рвоты у детей и подростков, получающих противоопухолевую терапию. Текущее состояние и потенциальные пути улучшения / Н.В. Жуков, Л.Л. Казакова, Г.А. Новичкова // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. – 2020. – Т. 19, № 4. – С. 205–223. doi: 10.24287/1726–1708-2020-19-4-205-223.